Suppression of Mesangial-Cell Proliferation by Trapidil in Glomerulonephritis Induced by Anti-Thymocyte Serum in Rats

Abstract

Trapadil (Mochida Pharmaceuticals, Japan), an antiplatelet drug, suppresses the growth of several cell types and is thought to antagonize platelet-derived growth factor. The effects of trapidil on mesangial-cell proliferation in glomerulonephritis induced by anti-thymocyte serum in Wistar rats were investigated. Control rats were treated with phosphate-buffered saline (group I); group II rats were injected with a single dose of anti-thymocyte serum (8 ml/kg body weight), and group III rats were treated with both a single dose of anti-thymocyte serum (8 ml/kg body weight) and with trapidil (5 mg/kg body weight/day). Three rats in each group were killed on day 3, and the other three on day 10. Control rats showed no significant histological changes on day 3 or day 10. In group II, on day 3, there was a marked decrease in glomerular cell numbers, with mesangiolysis. Histologically severe mesangial-cell proliferation with expansion of mesangial areas was noted on day 10. None of the rats in group III showed mesangial alterations, histologically, indicating that mesangial-cell proliferation was suppressed by trapidil. This suppression may result from antagonism of the binding of platelet derived growth factor to the specific surface receptors in the mesangial cells. Trapidil may have clinical value in the treatment of mesangial-cell proliferative glomerular diseases.

Keywords

Trapidil Anti-platelet drugs Glomerulonephritis Mesangial-cell proliferation Anti-thymocyte serum

Get full access to this article

View all access options for this article.

References

Ortiz

Gomez-Chiarri

Alonso

: The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases. J Lipid Mediat 1994; 9: 55–74.

Akai

Iwano

Kitamura

: Intra-glomerular expressions of IL-1 alpha and platelet-derived growth factor (PDGF-B) mRNA in experimental immune complex-mediated glomerulonephritis. Clin Exp Immunol 1994; 95: 29–34.

Barnes

Abboud

: Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am J Pathol 1993; 143: 1366–1376.

Iida

Seifert

Alpers

: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 1991; 88: 6560–6564.

Razzaque

Taguchi

: Similarities of intraglomerular collagen synthesis in IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol 1994; 7: 981.

Razzaque

Koji

Kawano

: Glomerular expression of type III and type IV collagens in benign nephrosclerosis: immunohistochemical and in situ hybridization study. Pathol Res Pract 1994; 190: 493–499.

Razzaque

Taguchi

: Increased expression of type III and type IV collagen in diabetic nephropathy. Diabetologia 1995; 38: 632–633.

Razzaque

Koji

Harada

: Primary focal segmental glomerulosclerosis is associated with increased intraglomerular type IV collagen synthesis. Clin Chim Acta 1995; 235: 121–124.

Razzaque

Koji

Taguchi

: In situ localization of type III and type IV collagen expressing cells in human diabetic nephropathy. J Pathol 1994; 174: 131–138.

10.

Isaka

Fujiwara

Ueda

: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. / Clin Invest 1993; 92: 2597–2601.

11.

Floege

Johnson

Alpers

: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol 1993; 142: 637–50.

12.

Veis

Yamashita

Liu

: The biology of mesangial cells in glomerulonephritis. Proc Soc Exp Biol Med 1990; 195: 160–167.

13.

Tohjima

Arisaka

Honda

: In vitro effects of trapidil on fatty acid and prostaglandin metabolism in platelets. Clin Ther 1994; 16: 405–415.

14.

Ohnishi

Yamaguchi

Shimada

: A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet derived growth factor. Life Sci 1981; 28: 1641–1646.

15.

Todo

Adams

Fahlbusch

: Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg 1993; 78: 463–469.

16.

Tada

Aida

Hosokawa

: Antiproliferative effect of trapidil on PDGF-associated growth of human glioma cell lines in vitro. Neurol Medi Chir (Tokyo) 1991; 31: 313–317.

17.

Kuratsu

Ushio

: Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro. J Neurosurg 1990; 73: 436–440.

18.

Okamoto

Inden

Setsuda

: Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1992; 123: 1439–1444.

19.

Liu

Roubin

Robinson

: Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 1990; 81: 1089–1093.

20.

Gesualdo

Di Paolo

Ranieri

: Trapidil inhibits human mesangial cell proliferation: effects on PDGF B-receptor binding and expression. Kidney Int 1994; 46: 1002–1009.

21.

Beitz

Riedel

Beitz

: The trapidil derivative AR 12456 protects against serum hyperlipidemia in guinea pigs. J Lipid Mediat 1991; 3: 177–186.

22.

Baldi

Emancipator

Hassan

: Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematous. Kidney Int 1990; 38: 1030–1038.

23.

Thaiss

Mihatsch

Oberle

: Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation. J Lab Clin Med 1994; 124: 775–781.

24.

Heldin

Ostman

Eriksson

: Platelet-derived growth factor: isoform-specific signalling via heterodimeric receptor complexes. Kidney Int 1992; 41: 571–574.

25.

Daniel

Kumjian

: Platelet-derived growth factor receptors and phospholipase C activation. Kidney Int 1992; 41: 575–580.

26.

Westermark

Claesson-Welsh

Heldin

C-H

: Structural and functional aspects of the receptors for platelet-derived growth factor. Prog Growth Factor Res 1989; 1: 253–266.

27.

Abboud

: Platelet-derived growth factor and mesangial cells. Kidney Int 1992; 41: 581–583.

28.

Gesualdo

Milani

Di Paolo

: Platelet-derived growth factor receptor expression in normal and glomerulo-nephritic human kidney: an immuno-histochemistry and in situ hybridization study. J Am Soc Nephrol 1993; 4: 687A.